PDF is available of LRG Science here.
It’s Time to Rethink Placebos in Advanced GIST
Authored by LRG Data Analyst Jerry Call
In this issue of LRG Science: based on current studies, this article asserts the belief that placebos do not benefit patients with advanced disease. The article illustrates the effect of placebos in trials and appeals to stakeholders to begin discussing alternatives and changes in order to save lives by extending the time on treatment instead of using placebos in advanced trials.
We welcome commentary on this article and invite new submissions for 2021 and 2022. To inquire further or to submit commentary, please email Mary Garland, Director of Communications: mgarland@liferaftgroup.org
